Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2026 11:11 ET | Source: Calian Group Ltd.

Calian tiendra une conférence téléphonique après l’annonce des résultats du premier trimestre de l’exercice 2026

OTTAWA, Ontario, 29 janv. 2026 (GLOBE NEWSWIRE) -- CalianMD Group Ltd. (TSX : CGY), une société de solutions essentielles axée sur la défense, l'espace, les soins de santé et d'autres secteurs...
January 29, 2026 11:11 ET | Source: Calian Group Ltd.

Calian to Hold Conference Call Following Announcement of First Quarter FY 2026 Results

Calian® Group Ltd., will hold a conference call at 8:30 a.m. Eastern Time on Thursday, February 12, 2026, to discuss the first quarter FY 2026 results.
January 23, 2026 08:00 ET | Source: Ocugen

Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock

MALVERN, Pa., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of its previously...
January 22, 2026 16:54 ET | Source: Corbin Advisors

Corbin Advisors Releases Q4’25 Inside The Buy-Side® Industrial Sentiment Survey®

Cautiously Optimistic Investor Sentiment Prevails as Intact Secular Growth Trends and Constructive Views on Order Rates Support Firm Setup in 2026
January 22, 2026 16:00 ET | Source: BitFuFu Inc.

BitFuFu Presenting at the 3rd Annual DealFlow Discovery Conference

BitFuFu will participate in the DealFlow Discovery Conference on January 28-29, 2026, where VP of IR Charley Brady will deliver a presentation.
January 22, 2026 09:00 ET | Source: Notified

How IR Teams Can Take Control of AI-Generated Answers in 2026

Join Notified on Jan. 29 for a live Q&A session addressing the most urgent AI questions from IR leaders.
January 21, 2026 08:32 ET | Source: Ocugen

Ocugen, Inc. Announces Pricing of $22.5 Million Offering of Common Stock

MALVERN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the pricing of its...
January 16, 2026 09:00 ET | Source: Corbin Advisors

Corbin Advisors Releases Q4’25 Inside The Buy-Side® Earnings Primer®

Survey Finds Investor Headiness for Growth Persists with Expectations Intact for 2026 Expansion but with Curbed Enthusiasm Somewhat.
January 13, 2026 09:00 ET | Source: Sonoco Products Company

Sonoco Announces Fourth Quarter Earnings Release and Investor Day Dates

Sonoco Announces Fourth Quarter Earnings Release and Investor Day Dates
January 08, 2026 08:00 ET | Source: Alps Group Inc

Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer

KUALA LUMPUR, Malaysia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (NASDAQ: ALPS) (the “Company” or “Alps Group”), a fully integrated biotechnology research and healthcare platform...